|

Perillyl alcohol Clinical Trials

1 actively recruiting trial across 1 location

Also known as: NEO100

Pipeline

Phase 1/2: 1

Top Sponsors

  • Neonc Technologies, Inc.1

Indications

  • Glioblastoma Multiforme1
  • Cancer1

Los Angeles, California1 trial

Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma

University of Southern California

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.